The report “Global Proton Therapy Market Outlook 2021” provides an in-depth analysis of global proton therapy treatment market with focus on major regional market such as North America, Europe and Asia Pacific. North America is the world’s largest proton therapy market with high predominance in the US. In Europe, Germany and the UK are major markets. The proton therapy systems market has been segmented into pencil beam scanning systems, uniform scanning systems and passive scattering systems on the basis of type of system. Out of these, pencil beam scanning being most precise form of proton therapy enjoys highest popularity.
Growth of the global proton therapy industry is driven by rise in cancer incidences, especially prostate cancer. Rising prevalence of chronic diseases in ageing population globally; and minimal invasiveness associated with use of proton therapy. However, major industry restraints include stringent regulations, high installation costs and reimbursement being limited to few uncommon cancer types. Global proton therapy industry is highly consolidated with three major players – IBA Proton Therapy Inc, Varian Medical Systems and Hitachi Limited dominating the market. These players have been profiled in the report.
Market Segmentation by Region
• North America
• The US
• Asia Pacific
• Europe
Key Vendors
• IBA Proton Therapy Inc
• Varian Medical Systems
• Hitachi Ltd
1. Executive Summary
2. Research Methodology
3. Proton Therapy
3.1 Background
3.2 Overview
1.1.1 Proton Therapy Devices
3.3 Classification
3.3.1 Type of System
3.3.2 Type of Treatment
4. Proton Therapy Market Analysis
4.1 Global Proton Therapy Market Sizing (Actual & Forecasted)
4.1.1 Global Proton Therapy Market Size by Value (Actual & Forecasted)
4.1.2 Global Proton Therapy Devices Market Size by Value (Actual & Forecasted)
4.1.4 Global Proton Therapy Market by Installed Base
4.1.5 Global Proton Therapy Facilities in Clinical Operation
4.1.7 Global Proton Therapy Market by New Treatment Rooms
4.1.8 Global Proton Therapy Market by Cumulative Treatment Rooms (Actual & Forecasted)
4.1.10 Global Proton Therapy Market by Patient Volume
5. Global Proton Therapy Market: Regional Analysis
5.1 North America
5.1.1 Proton Therapy Installated Base
5.1.2 Proton Therapy Facilities (Operational & Under-construction)
5.1.3 Patient Treatment Volume
5.2 Europe Proton Therapy Market
5.2.1 Proton Therapy Installed Base
5.2.2 Proton Therapy Facilities (Operational & Under-construction)
5.2.3 Patient Treatment Volume
5.3 Asia Proton Therapy Market
5.3.1 Proton Therapy Installed Base
5.3.2 Proton Therapy Facilities (Operational & Under-construction)
5.3.3 Patient Treatment Volume
6. Proton Therapy Market Dynamics
6.1 Industry Trends & Developments
6.1.1 HYPERSCAN Pencil Beam Scanning
6.1.2 Advent of Compact Proton Therapy Centers
6.2 Growth Drivers
6.2.1 Inrceasing Prevelance of Prostrate Cancer
6.2.2 Rising Cancer Incidences
6.2.3 Ageing Population
6.2.4 Minimally Invasive Nature
6.3 Challenges
6.3.1 High Installation Cost
6.3.2 Stringent Regulations
6.3.3 Reimbursement Limited to Uncommon Cancer
7. Competitive Landscape
7.1 Market share by Competitors
7.1.1 Overall Market
7.1.2 Systems
7.1.3 Installed Base
7.1.4 Order Share
7.2 Market Share by Room Sales
7.2.1 Global
7.2.2 North America
7.2.3 The US
7.2.4 Japan
7.2.5 Rest of Asia Pacific
7.2.6 Europe, Middle East & Africa and Rest of World
8. Company Profiles
8.1 IBA Proton Therapy Inc
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategies
8.2 Varian Medical Systems
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategies
8.3 Hitachi Ltd.
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategies
List of Tables
Table 1: Risk of Seondary Cancer Development in Children post Radiation Therapy
Table 2: Comparison of post-impact of Radiotherapy for Breast Cancer Patients
Table 3: Number of Proton Therapy Centers and Treatment Rooms by Region
Table 4: North America - Proton Therapy Facilities in Operation ( Till 2016)
Table 5: North America - Proton Therapy Facilities Under-Construction
Table 6: North America - Proton Therapy Facilities in Planning Stage
Table 7: Europe - Proton Therapy Facilities in Operation ( Till 2016)
Table 8: Europe - Proton Therapy Facilities Under-Construction (Till 2016)
Table 9: Europe - Proton Therapy Facilities in Planning Stage
Table 10: Asia - Proton Therapy Facilities in Operation (Till 2016)
Table 11: Asia - Proton Therapy Facilities Under-Construction
Table 12: Asia Proton Therapy Facilities in Planning Stage
Table 13: Incidence of Common Types of Cancer and Estimated Deaths (2016)
List of Figures
Figure 1: Cancer Treatment Options
Figure 2: Comparison of after-effects of Proton Therapy and X-ray Radiation on Prostrate Cancer Patients
Figure 3: Comparison to Results of Various Treatments for Lung Cancer
Figure 4: Global Proton Therapy Market Size by Value, 2008-15 (US$ Millions)
Figure 5: Global Proton Therapy Market Size by Value Forecasted, 2016E-21E (US$ Millions)
Figure 6: Global Proton Therapy Devices Market Size by Value, 2008-15 (US$ Millions)
Figure 7: Global Proton Therapy Devices Market Size by Value Forecasted, 2016E-21E (US$ Millions)
Figure 8: Global Proton Therapy Market by Installed Base, 2010-15 (Units)
Figure 9: Global Proton Therapy Facilites in Operation, 2010-15 (Units)
Figure 10: Global Proton Therapy Market - New Treatment Rooms, 2008-15 (Units)
Figure 11: Global Proton Therapy Market by Cumulative Treatment Rooms, 2008-15 (Units)
Figure 12: Global Proton Therapy Market by Cumulative Treatment Rooms Forecasted, 2016E-21E (Units)
Figure 13: Global Proton Therapy Market by Patient Volume, 2008-15 (Thousands)
Figure 14: Density of Proton Therapy Centers and Treatment Rooms by Region, 2016 (per 100 million population)
Figure 15: North America Proton Therapy Market by Installed Base; 2010-2015E (Units)
Figure 16: North America - Proton Therapy Patients Treatment Cumulative Volume; 2008-2015
Figure 17: Europe Proton Therapy Market by Installed Base; 2010-2015E (Units)
Figure 18: Europe & Russia - Proton Therapy Patients Treatment Cumulative Volume; 2008-2015
Figure 19: Asia - Proton Therapy Market by Installed Base; 2010-2015E (Units)]
Figure 20: Asia - Proton Therapy Patients Treatment Cumulative Volume; 2008-2015
Figure 21: Prostrate Cancer Incidences and Death Rates in the US, 2010-16
Figure 22: Average Number of Cancer Cases per Year and Age-Specific Incidence Rates, 2010-15
Figure 23: Global Ageing Population, 2008-16 (Millions)
Figure 24: Global Proton Therapy Market Share by Competitors, 2015-18E
Figure 25: Global Proton Therapy Installed Base Market Share by Systems (2016E)
Figure 26: Global Proton Therapy Installed Base Market Share by Competitors (2016E)
Figure 27: Global Proton Therapy Device Orders Market Share by Competitors (2015)
Figure 28: Global Proton Therapy Market Share by Room Sales (2015)
Figure 29: North America Proton Therapy Market Share by Facilities (till Sept’16)
Figure 30: North America Proton Therapy Market Share by Room Sales (till Sept’16)
Figure 31: North America Proton Therapy Market Share by Room Type (till Sept’16)
Figure 32: The US Proton Therapy Market Share by Number of Centers (till Sept’16)
Figure 33: The US Proton Therapy Market Share by Number of Rooms (till Sept’16)
Figure 34: Japan Proton Therapy Market Share by Number of Rooms (till Nov’16)
Figure 35: Rest of APAC Proton Therapy Market Share by Number of Rooms (till Nov’16)
Figure 36: EMEA & RoW Proton Therapy Market Share by Number of Rooms (till Nov’16)
Figure 37: IBA Proton Therapy Revenue by Business Segment (FY2016)
Figure 38: IBA Proton Therapy Revenue, FY2011-FY2016 (US$ Millions)
Figure 39: Varian Medical Systems Revenue by Business Segment (FY2016)
Figure 40: Varian Medical Systems Revenue, FY2011-FY2016 (US$ Millions)
Figure 41: Hitachi Ltd. Revenue by Business Segment (FY2016)
Figure 42: Hitachi Ltd. Revenue, FY2011-FY2016 (US$ Millions)
Table 1: Risk of Seondary Cancer Development in Children post Radiation Therapy
Table 2: Comparison of post-impact of Radiotherapy for Breast Cancer Patients
Table 3: Number of Proton Therapy Centers and Treatment Rooms by Region
Table 4: North America - Proton Therapy Facilities in Operation ( Till 2016)
Table 5: North America - Proton Therapy Facilities Under-Construction
Table 6: North America - Proton Therapy Facilities in Planning Stage
Table 7: Europe - Proton Therapy Facilities in Operation ( Till 2016)
Table 8: Europe - Proton Therapy Facilities Under-Construction (Till 2016)
Table 9: Europe - Proton Therapy Facilities in Planning Stage
Table 10: Asia - Proton Therapy Facilities in Operation (Till 2016)
Table 11: Asia - Proton Therapy Facilities Under-Construction
Table 12: Asia Proton Therapy Facilities in Planning Stage
Table 13: Incidence of Common Types of Cancer and Estimated Deaths (2016)
List of Figures
Figure 1: Cancer Treatment Options
Figure 2: Comparison of after-effects of Proton Therapy and X-ray Radiation on Prostrate Cancer Patients
Figure 3: Comparison to Results of Various Treatments for Lung Cancer
Figure 4: Global Proton Therapy Market Size by Value, 2008-15 (US$ Millions)
Figure 5: Global Proton Therapy Market Size by Value Forecasted, 2016E-21E (US$ Millions)
Figure 6: Global Proton Therapy Devices Market Size by Value, 2008-15 (US$ Millions)
Figure 7: Global Proton Therapy Devices Market Size by Value Forecasted, 2016E-21E (US$ Millions)
Figure 8: Global Proton Therapy Market by Installed Base, 2010-15 (Units)
Figure 9: Global Proton Therapy Facilites in Operation, 2010-15 (Units)
Figure 10: Global Proton Therapy Market - New Treatment Rooms, 2008-15 (Units)
Figure 11: Global Proton Therapy Market by Cumulative Treatment Rooms, 2008-15 (Units)
Figure 12: Global Proton Therapy Market by Cumulative Treatment Rooms Forecasted, 2016E-21E (Units)
Figure 13: Global Proton Therapy Market by Patient Volume, 2008-15 (Thousands)
Figure 14: Density of Proton Therapy Centers and Treatment Rooms by Region, 2016 (per 100 million population)
Figure 15: North America Proton Therapy Market by Installed Base; 2010-2015E (Units)
Figure 16: North America - Proton Therapy Patients Treatment Cumulative Volume; 2008-2015
Figure 17: Europe Proton Therapy Market by Installed Base; 2010-2015E (Units)
Figure 18: Europe & Russia - Proton Therapy Patients Treatment Cumulative Volume; 2008-2015
Figure 19: Asia - Proton Therapy Market by Installed Base; 2010-2015E (Units)
Figure 20: Asia - Proton Therapy Patients Treatment Cumulative Volume; 2008-2015
Figure 21: Prostrate Cancer Incidences and Death Rates in the US, 2010-16
Figure 22: Average Number of Cancer Cases per Year and Age-Specific Incidence Rates, 2010-15
Figure 23: Global Ageing Population, 2008-16 (Millions)
Figure 24: Global Proton Therapy Market Share by Competitors, 2015-18E
Figure 25: Global Proton Therapy Installed Base Market Share by Systems (2016E)
Figure 26: Global Proton Therapy Installed Base Market Share by Competitors (2016E)
Figure 27: Global Proton Therapy Device Orders Market Share by Competitors (2015)
Figure 28: Global Proton Therapy Market Share by Room Sales (2015)
Figure 29: North America Proton Therapy Market Share by Facilities (till Sept’16)
Figure 30: North America Proton Therapy Market Share by Room Sales (till Sept’16)
Figure 31: North America Proton Therapy Market Share by Room Type (till Sept’16)
Figure 32: The US Proton Therapy Market Share by Number of Centers (till Sept’16)
Figure 33: The US Proton Therapy Market Share by Number of Rooms (till Sept’16)
Figure 34: Japan Proton Therapy Market Share by Number of Rooms (till Nov’16)
Figure 35: Rest of APAC Proton Therapy Market Share by Number of Rooms (till Nov’16)
Figure 36: EMEA & RoW Proton Therapy Market Share by Number of Rooms (till Nov’16)
Figure 37: IBA Proton Therapy Revenue by Business Segment (FY2016)
Figure 38: IBA Proton Therapy Revenue, FY2011-FY2016 (US$ Millions)
Figure 39: Varian Medical Systems Revenue by Business Segment (FY2016)
Figure 40: Varian Medical Systems Revenue, FY2011-FY2016 (US$ Millions)
Figure 41: Hitachi Ltd. Revenue by Business Segment (FY2016)
Figure 42: Hitachi Ltd. Revenue, FY2011-FY2016 (US$ Millions)
List of Tables
IBA Proton Therapy Inc, Hitachi Ltd, Varian Medical Systems
Ěý
Ěý
*If Applicable.
